Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: | Femme-Tab ED 20/100 |
Active Ingredients: | Ethinylestradiol 20mcg Levonorgestrel 100mcg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | AFT Pharmaceuticals Limited |
Manufacturer: | Pharbil Waltrop GmbH, Waltrop, Germany |
Note: This consent is given subject to the following conditions:
|
|
Product: | Femme-Tab ED 30/150 |
Active Ingredients: | Ethinylestradiol 30mcg Levonorgestrel 150mcg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | AFT Pharmaceuticals Limited |
Manufacturer: | Pharbil Waltrop GmbH, Waltrop, Germany |
Note: This consent is given subject to the following conditions:
|
Dated this 16th day of July 2019.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).